Table 1.

Demographic and clinical details of samples

Factor	PDAC (n = 32)	HC (n = 32)	AIP (n = 32)
Age	59.31 ± 9.53	58.63 ± 10.28	58.83 ± 9.76
Gender (F/n)	21.87% (7)	18.75% (6)	18.75% (6)
BMI	23.21 ± 3.24	23.18 ± 3.07	24.37 ± 3.09
Hypertension (n)	34.38% (11)	25% (8)	6.25% (2)
Diabetes (n)	31.25% (10)	16% (5)	28.13% (9)
Jaundice (n)	25.00% (8)	0 (0)	0 (0)
Tumor location (n)
Pancreatic head	40.63% (13)	–	–
Pancreatic neck	12.50% (4)	–	–
Pancreatic body	3.13% (1)	–	–
Pancreatic tail	6.25% (2)	–	–
Pancreatic head and body	12.50% (4)	–	–
Pancreatic body and tail	25.00% (8)	–	–
TNS staging (n)
I	37.50% (12)	–	–
II	28.13% (9)	–	–
III	18.75% (6)	–	–
IV	15.63% (5)	–	–
CA-19–9 u/ml	137.10(15.54–379.60)	–	–

Data are expressed as mean ± SD or median (1st-3st quartile) according to the normality of distribution. F: female, PDAC: pancreatic ductal adenocarcinoma, AIP: autoimmune pancreatitis, HC: healthy control